{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:10:06Z","timestamp":1789852206171,"version":"4.0.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085028","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:06:52Z","timestamp":1389200812000},"page":"e85028","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["IL-15 Deficient Tax Mice Reveal a Role for IL-1\u03b1 in Tumor Immunity"],"prefix":"10.1371","volume":"9","author":[{"given":"Daniel A.","family":"Rauch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/eci.10.102","article-title":"Stimulating natural killer cells to protect against cancer: recent developments","volume":"7","author":"A Gillgrass","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2011.04.001","article-title":"Interleukin 15 as a promising candidate for tumor immunotherapy","volume":"22","author":"M Jakobisiak","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"MK Kennedy","year":"2000","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1073\/pnas.91.11.4935","article-title":"A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells","volume":"91","author":"JD Burton","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1073\/pnas.93.7.2897","article-title":"Interleukin (IL) 15\/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region\/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation","volume":"93","author":"R Bamford","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/0008-5472.CAN-08-3735","article-title":"Interleukin-15 enhances proteasomal degradation of Bid in normal lymphocytes. Implications for large granular lymphocyte leukemias","volume":"69","author":"DL Hodge","year":"2009","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood-2007-11-121871","article-title":"Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes","volume":"112","author":"MV Shah","year":"2008","journal-title":"Blood"},{"key":"ref8","first-page":"4802","article-title":"Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis","volume":"9","author":"H Kuniyasu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1182\/blood.V87.8.3327.bloodjournal8783327","article-title":"Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders","volume":"87","author":"L Trentin","year":"1996","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1182\/blood-2010-09-307504","article-title":"Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15R\u03b1","volume":"117","author":"N Sato","year":"2011","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ccr.2012.09.009","article-title":"Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation","volume":"22","author":"A Mishra","year":"2012","journal-title":"Cancer Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1073\/pnas.95.5.2452","article-title":"Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site","volume":"95","author":"N Azimi","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","first-page":"1057","article-title":"Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A","volume":"92","author":"WJ Grossman","year":"1995"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood-2008-07-166462","article-title":"Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors","volume":"113","author":"D Rauch","year":"2009","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1742-4690-6-116","article-title":"T cell activation promotes tumorigenesis in inflammation-associated cancer","volume":"6","author":"D Rauch","year":"2009","journal-title":"Retrovirology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.V98.4.1200","article-title":"The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors","volume":"98","author":"T Portis","year":"2001","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1182\/blood-2005-04-1730","article-title":"HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition","volume":"106","author":"L Gao","year":"2005","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"CA Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1189\/jlb.0905509","article-title":"Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1\u03b1","volume":"80","author":"T Dvorkin","year":"2006","journal-title":"J Leukoc Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cyto.2011.07.006","article-title":"IL-1 acts on T cells to enhance the magnitude of in vivo immune responses","volume":"56","author":"SZ Ben-Sasson","year":"2011","journal-title":"Cytokine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.171.12.6448","article-title":"Differential effects of IL-1 alpha and IL-1\u03b2 on tumorigenicity patterns and invasiveness","volume":"171","author":"X Song","year":"2003","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","article-title":"The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions","volume":"25","author":"RN Apte","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"ref23","first-page":"277","article-title":"Opposing effects of IL-1 alpha and IL-1\u03b2 on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1\u03b2 potentiates invasiveness","volume":"479","author":"RN Apte","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.4049\/jimmunol.0803916","article-title":"Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholanthrene tumor cells","volume":"182","author":"M Elkabets","year":"2009","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1593\/neo.08286","article-title":"Tumorigenicity of IL-1alpha- and IL-1 beta-deficient fibrosarcoma cells","volume":"10","author":"I Nazarenko","year":"2008","journal-title":"Neoplasia"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ijc.23503","article-title":"Opposing effects of fibrosarcoma cell-derived IL-1 alpha and IL-1 beta on immune response induction","volume":"123","author":"R Marhaba","year":"2008","journal-title":"Int J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.4049\/jimmunol.175.12.8200","article-title":"CD11b+\/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1 beta-secreting cells","volume":"175","author":"X Song","year":"2005","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1073\/pnas.0915018107","article-title":"Differential release of chromatin-bound IL-1\u03b1 discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation","volume":"107","author":"I Cohen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1074\/jbc.M306342200","article-title":"Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes","volume":"279","author":"M Buryskova","year":"2004","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1073\/pnas.0308705101","article-title":"The precursor form of IL-1\u03b1 is an intracrine proinflammatory activator of transcription","volume":"101","author":"A Werman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fimmu.2012.00290","article-title":"The transcription of the alarmin cytokine interleukin-1 alpha is controlled by hypoxia inducible factors 1 and 2 alpha in hypoxic cells","volume":"3","author":"P Rider","year":"2012","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1\u03b1 and IL-1\u03b2 recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"P Rider","year":"2011","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1086\/420832","article-title":"Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy","volume":"189","author":"PK Goon","year":"2004","journal-title":"J Infect Dis"},{"key":"ref34","first-page":"391953","article-title":"Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia\/Lymphoma?","volume":"2012","author":"AG Rowan","year":"2012","journal-title":"Leuk Res Treatment"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/JVI.70.8.4919-4926.1996","article-title":"Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response","volume":"70","author":"C Pique","year":"1996","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1182\/blood.V87.8.3410.bloodjournal8783410","article-title":"Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins","volume":"87","author":"N Mori","year":"1996","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1099\/jmm.0.033456-0","article-title":"Interleukin-1 alpha produced by human T-cell leukaemia virus type I-infected T cells induces intercellular adhesion molecule-1 expression on lung epithelial cells","volume":"60","author":"Y Nakayama","year":"2011","journal-title":"J Med Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1348-0421.1996.tb01082.x","article-title":"In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis","volume":"40","author":"K Sagawa","year":"1996","journal-title":"Microbiol Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.20737","article-title":"Potential immunogenicity of adult T cell leukemia cells in vivo","volume":"114","author":"K Kurihara","year":"2005","journal-title":"Int J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells","volume":"109","author":"S Takeda","year":"2004","journal-title":"Int J Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1172\/JCI113152","article-title":"Interleukin 1 gene expression in adult T cell leukemia","volume":"80","author":"Y Wano","year":"1987","journal-title":"J Clin Invest"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1078-0432.CCR-05-1603","article-title":"The role of interleukin 1 in growth and metastasis of human cancer xenografts","volume":"12","author":"DM Elaraj","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/art.10172","article-title":"Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells","volume":"46","author":"S Saijo","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10549-012-2287-y","article-title":"IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients","volume":"136","author":"MP Roberti","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.surg.2012.05.035","article-title":"Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines","volume":"152","author":"E Luedke","year":"2012","journal-title":"Surgery"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.exphem.2011.08.006","article-title":"Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression","volume":"39","author":"E Moga","year":"2011","journal-title":"Exp Hematol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1073\/pnas.0902637106","article-title":"Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer","volume":"106","author":"M Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.4049\/jimmunol.1102604","article-title":"Augmented IL-15R\u03b1 expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice","volume":"188","author":"M Zhang","year":"2012","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.1073\/pnas.0909474106","article-title":"Successful immunotherapy with IL-2\/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment","volume":"106","author":"JM Weiss","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","unstructured":"Hong DS, Naing A, Falchook GS, Piha-Paul S, Wheler JJ, <etal>et al<\/etal>. (2011) Abstract A211: A phase I study of MABp1, a first-in-human, first-true human monoclonal antibody against the IL-1 in patients with advanced cancers. Molecular Cancer Therapeutics 10: Supplement 1. doi: 10.1158\/1535-7163. TARG-11-A211."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T13:01:31Z","timestamp":1597323691000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085028"}},"subtitle":[],"editor":[{"given":"Zhi-Ming","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085028","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}